EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Combination therapy with lamivudine and low dosehepatitis-B immune globulin against hepatitis-B recurrence after liver transplantation

Fulya GÜNŞAR ¹ , Yaman TOKAT ² , Zeki KARASU ³ , Ulus Salih AKARCA ⁴ , Tijen ÖZACAR ⁴ , Gül YÜCE ⁵

Author Affiliation(s)

1.

Departments of Gastroenterology, Ege University School of Medicine, İzmir

2.

Ege University Medical School, Departments of General Surgery, İzmir

3.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı, İzmir

4.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji ve Mikrobiyoloji Anabilim Dalları, İzmir

5.

Ege Üniversitesi Tıp Fakültesi Radyoloji Anabilim Dalı, İzmir

Turk J Gastroenterol 2000; 11: 185-190

Keywords : Kronik hepatit B, karaciğer transplantas-yonu, lamivudin, hepatit B immün globulini.

Read: 1372 Published: 25 July 2019

Volume 11, Issue 3, September 2000

Previous Article